Module 5 of 5

How Long Have Peptides Been Around?

125 years. Peptides were first discovered in 1901, when Emil Fischer built the first peptide bond in a lab. Walk the timeline from that moment to today's GLP-1 revolution.

125 Years on One Timeline

Peptide science begins in 1901 with a single lab bond and runs straight through to today's $30B GLP-1 era. Click any milestone below to see what happened, who did it, and why it mattered.

interactive

Era 1 -- The Pioneers (1901-1953)

Three people. Three breakthroughs. Together they turned peptides from a curiosity into a science -- proving the building blocks of life could be built, injected, and read.

1901

Emil Fischer

first lab-built peptide

Stitched two amino acids into glycylglycine and coined the word peptide from the Greek peptein (to digest). Proved life's building blocks could be assembled by human hands.

1922

Banting & Best

insulin saves Leonard Thompson

A 14-year-old dying of type 1 diabetes was injected with pancreatic extract in Toronto. He recovered. Insulin became the first peptide to save a human life.

1953

Frederick Sanger

first sequenced protein (12 years of work)

Spent 12 years piecing insulin together like a jigsaw with no picture on the box. Showed proteins aren't random blobs -- they're precise machines.

The Thompson moment. Before 1922, a type 1 diabetes diagnosis was a death sentence -- usually within a year. One injection of insulin changed Thompson's blood sugar overnight. Within twelve months, the same extract was being mass-produced from animal pancreas and shipped worldwide.

Era 2 -- The Synthesis Revolution (1963-1982)

Knowing a peptide's recipe was one thing. Building it was another. Two breakthroughs -- one chemical, one biological -- turned peptides from rare lab samples into industrial drugs.

before 1963

peptide synthesis was brutal

months per peptide

Even a short peptide meant months of painstaking solution chemistry: add one amino acid, purify, add the next, purify again. Each intermediate had to be isolated by hand.

after 1963 (Merrifield)

solid-phase synthesis (SPPS)

days per peptide -- Nobel Prize 1984

Bruce Merrifield anchored the first amino acid to a tiny resin bead so it couldn't wash away. The chain grew one link at a time without ever isolating intermediates.

1977

Genentech reprograms E. coli

first bacteria-made human peptide

Spliced a human gene into bacteria and produced somatostatin. For the first time, a living cell was reprogrammed to manufacture a human peptide on demand.

1982

Humulin approved by FDA

first recombinant DNA drug ever sold

Human insulin grown in bacterial vats instead of harvested from pig pancreases. We no longer needed to borrow molecules from animals -- we could tell bacteria what to build.

Merrifield's deceptively simple idea. Anchor the first amino acid to a bead. Build everything else on top. The peptide stays put while you wash reagents through it. That single shift collapsed months into days and made every later peptide drug practically possible.

Era 3 -- The Discovery Era (1992-2005)

Once we could build peptides, the next question was where to find new ones. The most important answer came from somewhere nobody was looking.

"Here's a question nobody was asking in the early 1990s: what's in Gila monster spit?"

John Eng, an endocrinologist at a Bronx VA hospital, had a hunch. Venomous animals rapidly disrupt their prey's metabolism -- so their venom might be packed with useful peptides. Gila monsters eat only three or four times a year, and their venom aggressively regulates blood sugar during those rare meals. Eng isolated exendin-4: it mimicked human GLP-1, the hormone that triggers insulin release. The catch? Your body's own GLP-1 breaks down in about two minutes. The lizard version lasted hours.

1992 → 2005

13 years from venom to pharmacy

exenatide (Byetta) -- FDA approval

In 2005, the FDA approved exenatide (brand name Byetta) -- the first GLP-1 receptor agonist, built directly from a desert reptile's venom. Nobody knew it yet, but this was the seed of a $30 billion revolution.


Era 4 -- The GLP-1 Revolution (2017-2024)

Novo Nordisk solved the half-life problem with a fatty-acid tail that hitches a ride on albumin in your blood. One injection, once a week. What followed wasn't a drug launch -- it was a cultural event.

2017

Ozempic

type 2 diabetes -- Novo Nordisk

Mechanism: GLP-1 agonist
Weight loss: ~10-12%
Impact: proved once-weekly peptide dosing works at scale.

2021

Wegovy

obesity -- Novo Nordisk

Mechanism: GLP-1 agonist (higher dose)
Weight loss: ~15%
Impact: numbers previously only seen with bariatric surgery.

2022

Mounjaro

type 2 diabetes -- Eli Lilly

Mechanism: GLP-1 + GIP dual agonist
Weight loss: up to 22.5%
Impact: proved multi-receptor agonists outperform single targets.

The cultural moment. Celebrities posted. Demand exploded. Shortages spread worldwide. By 2024, GLP-1 drugs were generating over $30 billion a year, compounding pharmacies were racing to make copies, and the FDA was scrambling to draw new regulatory lines. In seven years, a niche diabetes drug class had reshaped how the world thinks about obesity.

The Four Eras at a Glance

Each era solved the problem the previous one created -- discovery → manufacture → biology → medicine at scale.

Era 1 · 1901-1953

Pioneers

Fischer · Banting · Sanger

Defined what a peptide is, proved one can save a life, mapped the first sequence.

Era 2 · 1963-1982

Synthesis Revolution

Merrifield · Genentech

SPPS shortened synthesis from months to days; Humulin made bacteria the new factory.

Era 3 · 1992-2005

Discovery Era

John Eng · Byetta

Gila monster venom delivered exenatide -- the first GLP-1 receptor agonist drug.

Era 4 · 2017-2024

GLP-1 Revolution

Ozempic · Wegovy · Mounjaro

Once-weekly peptides reshaped obesity medicine and built a $30B drug class.


What's Next? Three Races, Right Now

Three races are happening simultaneously, and each could change what peptide therapy looks like within the next few years.

Race 1

the end of needles

oral GLP-1 agonists

Oral semaglutide proved a peptide can survive stomach acid, barely. Orforglipron and danuglipron are small-molecule GLP-1 agonists built to be swallowed like aspirin. If they work, injections become optional.

Race 2

stacking receptors

multi-receptor agonists

Tirzepatide hits two receptors. Retatrutide hits three -- GLP-1, GIP, and glucagon -- and phase 2 trials showed 24% body weight loss. If phase 3 confirms, it would be the most effective weight-loss drug ever made.

Race 3

AI-designed peptides

Nuritas, Peptone

Nuritas and Peptone are using machine learning to design peptides evolution never produced -- optimized for stability, potency, and targets no natural peptide has ever hit.


Common Questions About Peptide History

Short, sourced answers to the questions people ask most about when peptides were discovered, who discovered them, and how old the science really is.

When were peptides discovered?

Peptides were discovered in 1901, when Emil Fischer built the first peptide bond in a lab by joining two amino acids into glycylglycine and coined the word peptide. That makes peptide science about 125 years old as of 2026.

Who discovered peptides?

Emil Fischer is credited with discovering peptides in 1901. Frederick Sanger later sequenced insulin in 1953, and Bruce Merrifield invented solid-phase synthesis in 1963 -- work that won the 1984 Nobel Prize in Chemistry.

Are peptides natural or synthetic?

Both. Peptides occur naturally in every living organism -- insulin, oxytocin, and glucagon are natural peptides -- and they can also be made synthetically. Lab-made peptides are chemically identical to their natural counterparts; only the production method differs.

What was the first peptide drug?

Insulin. In 1922 it saved 14-year-old Leonard Thompson, who was dying of type 1 diabetes in Toronto. In 1982, Humulin became the first recombinant-DNA peptide drug, made by reprogramming bacteria to produce human insulin.


  1. Galanis AS et al. "The bold legacy of Emil Fischer." Chemistry. 2009;15(38):9696-705. PMID 14552421
  2. Hegele RA, Bhatt DL. "The discovery of insulin revisited: lessons for the modern era." J Clin Invest. 2021;131(1):e142239. PMID 33393501
  3. Stretton AOW. "The first sequence: Fred Sanger and insulin." Genetics. 2002;162(2):527-532. PMID 12399368
  4. Mitchell AR. "Bruce Merrifield and solid-phase peptide synthesis: a historical assessment." Biopolymers. 2008;90(3):175-84. PMID 18213693
  5. Parkes DG et al. "Discovery and development of exenatide." Expert Opin Drug Discov. 2013;8(2):219-44. PMID 23231438
  6. Jastreboff AM et al. "Tirzepatide Once Weekly for the Treatment of Obesity." N Engl J Med. 2022;387(4):327-340. PMID 35658024
  7. Jastreboff AM et al. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity -- A Phase 2 Trial." N Engl J Med. 2023;389(6):514-526. PMID 37366315
  8. Quianzon CC, Cheikh I. "100 Years since the Discovery of Insulin." Diabetologia. 2024. PMID 38540146
  9. Kimmerlin T, Seebach D. "'100 years of peptide synthesis': ligation methods for peptide and protein synthesis." J Pept Res. 2005. PMID 15705167

Knowledge Check

Test what you learned in this module.

Practice Exercises

Reinforce your understanding with interactive exercises.

Completed all free modules!

Explore Peptide Courses